-
MDS: Phase 3 Trial Explores Novel Treatment Strategy
22 Sep 2025 13:22 GMT
… may have developed bias in treatment assignment due to observable side … study was supported by Syros Pharmaceuticals Inc. Amy DeZern, MD, disclosed … , Bristol Myers Squibb, Novartis, Kura, Geron, Servier, Keros, and Shattuck Labs …
-
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Sep 2025 20:01 GMT
… , 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial … to continued employment with Geron through the applicable vesting … under the plan. About Geron
Geron is a commercial-stage … European Union for the treatment of certain adult patients …
-
What Do Investors Think About Geron Corporation (GERN) Following Q2 Results?
31 Aug 2025 04:32 GMT
… stocks to buy right now. Geron Corporation (NASDAQ:GERN) reported … revenue in the quarter. Is Geron Corp. (GERN) the Best … reiterated a Buy rating on Geron Corporation (NASDAQ:GERN), keeping … .72% from current levels. Geron Corporation (NASDAQ:GERN) is a …
-
Needham Keeps Buy Rating on Geron (GERN) After Q2 Results
24 Aug 2025 22:29 GMT
… reiterated its Buy rating for Geron Corporation (NASDAQ:GERN) with a price … highlighted the strong performance of Geron Corporation’s (NASDAQ:GERN) RYTELO in … the new CEO of Geron Corporation (NASDAQ:GERN). Geron Corporation (NASDAQ:GERN) is a …
-
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors
19 Aug 2025 12:00 GMT
… , Chief Executive Officer of SpyGlass Pharma. “Her prior experience managing multinational … ., Lensar Inc. (NASDAQ: LNSR) and Geron Corporation, where she also serves as … Indiana University Bloomington. ABOUT SPYGLASS PHARMA The SpyGlass Drug Delivery Platform …
-
Geron Corporation Investors: Company Investigated by the Portnoy Law Firm
14 Aug 2025 21:23 GMT
… The Portnoy Law Firm advises Geron Corporation (“Geron” or “the Company”) (NASDAQ: GERN … action on behalf of investors. Geron investors that lost money on … Defendants repeatedly expressed confidence in Geron’s ability to capitalize on …
-
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
13 Aug 2025 23:52 GMT
… is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf … board of directors of Geron have breached their fiduciary … other things, confidence in Geron's ability to … a long-term stockholder of Geron, have information, would …
-
The Escalator: Geron, Vertex Pharmaceuticals, Butler/Till and more
07 Aug 2025 04:39 GMT
New hires:
Geron named Harout Semerjian as president … seven new appointees.
Departures:
Vertex Pharmaceuticals’ longtime chief scientific officer David …
-
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025
28 Jul 2025 12:19 GMT
… BUSINESS WIRE)--Jul 28, 2025--
Geron Corporation (Nasdaq: GERN), a commercial … the European Union for the treatment of certain adult patients … CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Geron Corporation
Copyright Business Wire …
-
Geron Corp. Posts Narrower Loss In Q1
07 May 2025 19:15 GMT
Geron Corp. (GERN) posted a first quarter … .
As of March 31, 2025, Geron had approximately $457.5 million …
About
© 1995-2025